Literature DB >> 8179300

Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.

I A Simpson1, K R Chundu, T Davies-Hill, W G Honer, P Davies.   

Abstract

Glucose metabolism is depressed in the temporal and parietal regions of the cortex in patients with Alzheimer's disease. We measured the concentrations of two glucose transporters, GLUT1 and GLUT3, in six regions of brains from both control subjects and patients with Alzheimer's disease. The concentrations of both transporters were reduced in the cerebral cortex, with larger and highly significant reductions observed for GLUT3, the putative neuronal glucose transporter. The reductions in GLUT3 were greater than the loss of synapses, and should be considered as a potential cause of the deficits in glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8179300     DOI: 10.1002/ana.410350507

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  120 in total

1.  Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation.

Authors:  L Lin; B Georgievska; A Mattsson; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

Review 2.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

3.  Chronic stress modulates regional cerebral glucose transporter expression in an age-specific and sexually-dimorphic manner.

Authors:  Sean D Kelly; Constance S Harrell; Gretchen N Neigh
Journal:  Physiol Behav       Date:  2013-12-29

4.  Age-related memory impairments due to reduced blood glucose responses to epinephrine.

Authors:  Ken A Morris; Qing Chang; Eric G Mohler; Paul E Gold
Journal:  Neurobiol Aging       Date:  2009-01-28       Impact factor: 4.673

Review 5.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

6.  Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.

Authors:  Joshua B Owen; Fabio Di Domenico; Rukhsana Sultana; Marzia Perluigi; Chiara Cini; William M Pierce; D Allan Butterfield
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

Review 7.  Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.

Authors:  C-X Gong; K Iqbal
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 8.  The role of novel chitin-like polysaccharides in Alzheimer disease.

Authors:  Rudy J Castellani; George Perry; Mark A Smith
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

9.  Attachment of PC12 cells to adhesion substratum induces the accumulation of glucose transporters (GLUTs) and stimulates glucose metabolism.

Authors:  D S Dwyer; H B Pinkofsky; Y Liu; R J Bradley
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

Review 10.  Deregulation of brain insulin signaling in Alzheimer's disease.

Authors:  Yanxing Chen; Yanqiu Deng; Baorong Zhang; Cheng-Xin Gong
Journal:  Neurosci Bull       Date:  2014-03-20       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.